These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 4435958)

  • 41. [Immunogenic activity of the influenza virus dependent on ne uraminidase (author's transl)].
    Isaeva EI; Rovnova AI; Kosiakov PN
    Vopr Virusol; 1975; (5):525-8. PubMed ID: 1210315
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Formation of antibodies against neuraminidase of A/California/07/2009 (H1N1) influenza virus after immunization with live monovalent influenza vaccine].
    Smolonogina TA; Desheva IuA; Shaldzhian AA; Grudinin MP; Rudenko LG
    Zh Mikrobiol Epidemiol Immunobiol; 2011; (6):72-6. PubMed ID: 22308734
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Independent variation in nature of hemagglutinin and neuraminidase antigens of influenza virus: distinctiveness of hemagglutinin antigen of Hong Kong-68 virus.
    Schulman JL; Kilbourne ED
    Proc Natl Acad Sci U S A; 1969 Jun; 63(2):326-33. PubMed ID: 5257124
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The protection of ferrets against influenza by immunization with a split influenza vaccine.
    Brady MI; Furminger IG
    Dev Biol Stand; 1975; 28():167-72. PubMed ID: 1126566
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Use of single radial immunodiffusion test for serological studies in volunteers inoculated with live attenuated influenza virus.
    Molyneux ME; Beare AS; Callow K; Schild GC
    J Hyg (Lond); 1974 Oct; 73(2):287-95. PubMed ID: 4214175
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of "Hong Kong" vaccine in preventing "England" variant influenza A in 1972.
    Stiver HG; Graves P; Eickhoff TC; Meiklejohn G
    N Engl J Med; 1973 Dec; 289(24):1267-71. PubMed ID: 4127183
    [No Abstract]   [Full Text] [Related]  

  • 47. The adjuvant effect of Sophy β-glucan to the antibody response in poultry immunized by the avian influenza A H5N1 and H5N2 vaccines.
    Le T; Le T; Doan TH; Quyen D; Le KX; Pham V; Nagataki M; Nomura H; Ikeue Y; Watanabe Y; Agatsuma T
    J Microbiol Biotechnol; 2011 Apr; 21(4):405-11. PubMed ID: 21532325
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Influenza A neuraminidase antibody assay with sensitized erythrocytes.
    Holston JL; Dowdle WR
    Appl Microbiol; 1973 Jan; 25(1):97-102. PubMed ID: 4631440
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In ovo vaccination of chicken embryos with experimental Newcastle disease and avian influenza oil-emulsion vaccines.
    Stone H; Mitchell B; Brugh M
    Avian Dis; 1997; 41(4):856-63. PubMed ID: 9454919
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antigenic variation in current influenza A viruses: evidence for a high frequency of antigenic 'drift' for the Hong Kong virus.
    Schild GC; Oxford JS; Dowdle WR; Coleman M; Pereira MS; Chakraverty P
    Bull World Health Organ; 1974; 51(1):1-11. PubMed ID: 4218138
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy of A/H1N1/2009 split inactivated influenza A vaccine (GC1115) in mice and ferrets.
    Han HJ; Song MS; Park SJ; Byun HY; Robles NJC; Ha SH; Choi YK
    J Microbiol; 2019 Feb; 57(2):163-169. PubMed ID: 30706345
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Potentiation of the antibody response to inactivated A2-Hong Kong vaccines by previous heterotypic influenza virus infection.
    Potter CW; Jennings R; Marine WM; McLaren C
    Microbios; 1973; 8(30):101-10. PubMed ID: 4801251
    [No Abstract]   [Full Text] [Related]  

  • 53. Development of antibodies to neuraminidase of A2-Hong Kong and A2-Taiwan influenza viruses after administration of different Hong Kong vaccines and after natural infection in humans.
    Závadová H
    Acta Virol; 1973 Jul; 17(4):287-92. PubMed ID: 4148207
    [No Abstract]   [Full Text] [Related]  

  • 54. Antibody titer has positive predictive value for vaccine protection against challenge with natural antigenic-drift variants of H5N1 high-pathogenicity avian influenza viruses from Indonesia.
    Swayne DE; Suarez DL; Spackman E; Jadhao S; Dauphin G; Kim-Torchetti M; McGrane J; Weaver J; Daniels P; Wong F; Selleck P; Wiyono A; Indriani R; Yupiana Y; Sawitri Siregar E; Prajitno T; Smith D; Fouchier R
    J Virol; 2015 Apr; 89(7):3746-62. PubMed ID: 25609805
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reactogenicity, immunogenicity, and antibody persistence in adults given inactivated influenza virus vaccines - 1978.
    Cate TR; Couch RB; Parker D; Baxter B
    Rev Infect Dis; 1983; 5(4):737-47. PubMed ID: 6622888
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Local and systemic antibody response after vaccination with 3 different types of vaccines against influenza. II. Neuraminidase inhibiting antibodies (author's transl)].
    Werner J; Kuwert EK; Stegmaier R; Simböck H
    Zentralbl Bakteriol A; 1980 Feb; 246(1):1-9. PubMed ID: 7424233
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Safety and immunogenicity of adjuvanted inactivated split-virion and whole-virion influenza A (H5N1) vaccines in children: a phase I-II randomized trial.
    Wu J; Liu SZ; Dong SS; Dong XP; Zhang WL; Lu M; Li CG; Zhou JC; Fang HH; Liu Y; Liu LY; Qiu YZ; Gao Q; Zhang XM; Chen JT; Zhong X; Yin WD; Feng ZJ
    Vaccine; 2010 Aug; 28(38):6221-7. PubMed ID: 20638454
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The stability and immunogenicity of inactivated MDCK cell-derived influenza H7N9 viruses.
    Tzeng TT; Lai CC; Weng TC; Cyue MH; Tsai SY; Tseng YF; Sung WC; Lee MS; Hu AY
    Vaccine; 2019 Nov; 37(47):7117-7122. PubMed ID: 31383484
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dose-response relationship after immunization of volunteers with a new, surface-antigen-adsorbed influenza virus vaccine.
    Potter CW; Jennings R; Phair JP; Clarke A; Stuart-Harris CH
    J Infect Dis; 1977 Mar; 135(3):423-31. PubMed ID: 850080
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A comparison of live and inactivated influenza A (H1N1) virus vaccines. 1. Short-term immunity.
    Clark A; Potter CW; Jennings R; Nicholl JP; Langrick AF; Schild GC; Wood JM; Tyrrell DA
    J Hyg (Lond); 1983 Jun; 90(3):351-9. PubMed ID: 6863909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.